title: Acute hepatitis C virus in an HIV clinic: a screening strategy, risk factors, and perception of risk.
abstract: Acute hepatitis C virus (HCV) infection is being acquired undetected among HIV-infected individuals. A practical way to regularly screen HIV-infected patients for acute HCV irrespective of perceived risk or symptoms is needed. We piloted implementation of an acute HCV screening strategy using routine HIV clinical care schedules and the least costly blood tests, in a Rhode Island HIV care center. Study participants had ongoing HCV risk, completed questionnaires encompassing risk behaviors and perception of risk, and were screened with quarterly alanine aminotransferase (ALT). ALT rise triggered HCV RNA testing, with pooled rather than individual specimen HCV RNA testing for underinsured participants. Participants were primarily older, college-educated men who have sex with men (MSM) with history of sexually transmitted infection other than HIV. One of 58 participants developed acute HCV in 50 person-years of observation for an annual incidence of 2.0% per year (95% confidence interval [CI] 0.05-11.1%). The majority (54%) of MSM did not perceive that traumatic sexual and drug practices they were engaging in put them at risk for HCV. Unprotected sex often occurred under the influence of drugs or alcohol. Self-reported HCV risk and participation in several risk behaviors declined during the study. It was possible to collect frequent ALTs in a busy HIV clinic with 71% of total projected ALTs obtained and 88% of participants having at least one ALT during the 9-month follow-up period. All instances of ALT rise led to reflexive HCV RNA testing. Tracking quarterly ALT for elevation to systematically prompt HCV RNA testing before seroconversion is a promising approach to screen for acute HCV in a real-world HIV clinical setting.
authors.affiliation: Department of Medicine, Division of Infectious Disease, Brown University, Providence, Rhode Island 02906, USA. ltaylor@lifespan.org
authors.forename: L E
authors.initials: LE
authors.lastname: Taylor
authors.forename: A K
authors.initials: AK
authors.lastname: DeLong
authors.forename: M A
authors.initials: MA
authors.lastname: Maynard
authors.forename: S
authors.initials: S
authors.lastname: Chapman
authors.forename: P
authors.initials: P
authors.lastname: Gholam
authors.forename: J T
authors.initials: JT
authors.lastname: Blackard
authors.forename: J
authors.initials: J
authors.lastname: Rich
authors.forename: K H
authors.initials: KH
authors.lastname: Mayer
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood*; D000554:Ambulatory Care Facilities / Q000706:statistics & numerical data*; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D007722:Health Knowledge, Attitudes, Practice; D016174:Hepacivirus / Q000235:genetics / Q000302:isolation & purification*; D006526:Hepatitis C / Q000175:diagnosis* / Q000453:epidemiology / Q000821:virology; D018451:Homosexuality, Male / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods*; D008875:Middle Aged; D012237:Rhode Island / Q000453:epidemiology; D012306:Risk; D012307:Risk Factors; D012725:Sexual Behavior; D012749:Sexually Transmitted Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000821:virology; D011795:Surveys and Questionnaires; D055815:Young Adult
chemical_list: D000410:Alanine Transaminase